4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-043729
Options or other derivatives
- Chief Medical Officer acquired 6,265 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Bowden Christopher Chief Medical Officer | 2018-07-20 | Grant or award · Performance share units | +6,265 | 6,265 | D | ||
Loading xslF345X03/doc4.xml…